![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjDpqTXW1cEBAISd3EW_HrohFmEgRnDhSWi4EanFrqqhe_3Lvi4YfcUqSEOmj618QCtxYaC0uHqFBkSwG__JOfVNLF7ZjfxLYh-CJ_9RBTGn6uuWgYZA3S38XnZvop14XSTi_89WYQTHlw/s320/ngc_email_hdr.gif)
GUIDELINE TITLE 2 - hematopoietic stem cell transplantation
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children.
BIBLIOGRAPHIC SOURCE(S)
Executive Committee, American Society for Blood and Marrow Transplantation. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children. Biol Blood Marrow Transplant 2007 Apr;13(4):500-1. [1 reference] PubMed
Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, Sanders JE, Smith FO 3rd, Wilmot F, McCarthy PL Jr, Hahn T. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant 2007 Jan;13(1):1-25. [69 references] PubMed
GUIDELINE STATUS
This is the current release of the guideline.
abrir aquí para acceder al documento NGC AHRQ completo:
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in c
No hay comentarios:
Publicar un comentario